WSTAM
CELG

Wilbanks Smith & Thomas Asset Management’s Celgene Corp CELG Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,950
Closed -$365K – 454
2019
Q2 		$365K Sell
3,950
-80
-2% -$7.6K 0.02% 277
2019
Q1 		$380K Hold
4,030
– – 0.02% 275
2018
Q4 		$258K Buy
4,030
+660
+20% +$48.7K 0.02% 289
2018
Q3 		$302K Sell
3,370
-200
-6% -$17.7K 0.02% 303
2018
Q2 		$284K Buy
3,570
+206
+6% +$17.1K 0.02% 272
2018
Q1 		$300K Sell
3,364
-458
-12% -$44K 0.02% 261
2017
Q4 		$399K Buy
3,822
+133
+4% +$15K 0.03% 225
2017
Q3 		$538K Buy
3,689
+234
+7% +$31.9K 0.05% 188
2017
Q2 		$449K Sell
3,455
-50
-1% -$6.13K 0.04% 195
2017
Q1 		$436K Sell
3,505
-286
-8% -$34.2K 0.04% 186
2016
Q4 		$439K Sell
3,791
-285
-7% -$31.7K 0.04% 178
2016
Q3 		$426K Sell
4,076
-314
-7% -$34K 0.04% 179
2016
Q2 		$433K Sell
4,390
-45
-1% -$4.66K 0.05% 177
2016
Q1 		$444K Buy
4,435
+290
+7% +$29.9K 0.05% 176
2015
Q4 		$496K Sell
4,145
-515
-11% -$59.6K 0.05% 164
2015
Q3 		$504K Sell
4,660
-341
-7% -$42.3K 0.07% 147
2015
Q2 		$579K Sell
5,001
-1,481
-23% -$169K 0.06% 164
2015
Q1 		$747K Sell
6,482
-262
-4% -$31.3K 0.07% 139
2014
Q4 		$754K Sell
6,744
-198
-3% -$20.9K 0.08% 141
2014
Q3 		$658K Buy
6,942
+2
+0% +$180 0.07% 138
2014
Q2 		$596K Sell
6,940
-358
-5% -$27.2K 0.06% 159
2014
Q1 		$509K Sell
7,298
-26,910
-79% -$2.13M 0.06% 173
2013
Q4 		$2.89M Buy
34,208
+824
+2% +$65.2K 0.34% 49
2013
Q3 		$2.57M Buy
33,384
+352
+1% +$24.7K 0.34% 51
2013
Q2 		$1.93M Buy
+33,032
New +$1.99M 0.3% 61

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's CELG Position: Q3 2019 in Review

Wilbanks Smith & Thomas Asset Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 3,950 shares — an estimated $365K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $2.89M in Q4 2013. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 3,950 Celgene Corp shares in Q3 2019, an estimated $365K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Wilbanks Smith & Thomas Asset Management's Celgene Corp position peaked at $2.89M in Q4 2013.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q3 2019, filed 6 Nov 2019.